ArticleScientific reports2024
Multiple elite strategy enhanced RIME algorithm for 3D UAV path planning.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- EBBO: A Biomimetically Enhanced Optimization Algorithm with Multi-Stage Cooperation for Complex Engineering Applications.Biomimetics (Basel, Switzerland) · 2026Article
- An Economic Scheduling Management Method for Microgrids Using Multi-Strategy Improved Sand Cat Swarm Optimization.Biomimetics (Basel, Switzerland) · 2025Article
- DRIME: A Distributed Data-Guided RIME Algorithm for Numerical Optimization Problems.Biomimetics (Basel, Switzerland) · 2025Article
- A spherical vector-based adaptive evolutionary particle swarm optimization for UAV path planning under threat conditions.Scientific reports · 2025Article
- A Novel Hybrid Improved RIME Algorithm for Global Optimization Problems.Biomimetics (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
With the wave of artificial intelligence sweeping the world in recent years, UAVs is widely used in various fields. UAV path planning has attracted much attention from scientists as an essential part of UAV work. In order to design an efficient and reasonable 3D UAV path planning program, recent researchers have invented and improved many algorithms. This paper proposes an elite RIME algorithm for 3D UAV path planning. First, we propose an elite reverse learning population selection strategy based on piecewise mapping to enhance the population diversity of the algorithm for better exploration. Second, this paper proposes a stochastic factor-controlled elite pool exploration strategy so that the algorithm is difficult to enter the local optimum and can better explore the global optimum. Then, this paper proposes a hard frost puncture exploitation strategy based on the sine-cosine function so that the algorithm can find the global optimum faster during the exploitation process. Meanwhile, in order to test the performance of the algorithm proposed in this paper, we compare it with 13 other intelligent optimization algorithms that are classical and popular nowadays on 52 test functions in three test sets, CEC2017, CEC2020, and CEC2022, and obtain competitive results. Finally, we applied it to the 3D UAV path planning problem in three different terrain scenarios, and the ELRIME algorithm achieved good results in all of them. Especially in the 7-peak model, the ELRIME algorithm improves the performance of the RIME algorithm by a factor of two. In the 9-peak model, the average value aspect also reduce the cost by 91 compared to the RIME algorithm, and more importantly, it has the smallest fluctuation in 30 runs, which is among the most stable of all the compared algorithms. In the 12-peak model, its stability is also significantly enhanced, and in terms of worst-case cost, it improves the cost by 340 compared to RIME.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.